scholarly journals Pueraria tuberosa as Dipeptidyl-Peptidase-IV Inhibitor Prevents Streptozotocin-Induced Intestinal Stress

2021 ◽  
Vol 9 (A) ◽  
pp. 28-34
Author(s):  
Shivani Srivastava ◽  
Harsh Pandey ◽  
Surya Kumar Singh ◽  
Yamini Bhusan Tripathi

BACKGROUND: Enhanced expression of PTY-2 dipeptidyl-peptidase-IV (DPP-IV) has been found to improve has been found in various intestinal diseases. Pueraria tuberosa tuber water extract-2 (PTY-2) is already known to have DPP-IV inhibitory potential. At the mRNA level, this inhibition has not yet been investigated. Increased incretin secretion due to inhibition of DPP-IV could lead to the suppression of stress and apoptosis of intestinal cells. AIM: In this research, we tried to study the antioxidant, anti-apoptotic, and DPP-IV inhibitory effect of PTY 2 against intestinal damage induced by STZ. METHODS: We found morphological damage to the intestine following streptozotocin (STZ) injection (65 mg/kg bw) in male Charles foster rats through histological examination. Superoxide dismutase (SOD) and DPP-IV mRNA expressions were analyzed by polymerase chain reaction and cell apoptosis was examined by tunnel assay and Bcl 2 immunoexpression. RESULTS: In STZ-induced diabetic control, the number and length of villi were decreased, but these damages were reversed by 10 days of PTY-2 treatment. SOD expression was found to be decreased whereas DPP-IV expression was enhanced with significant intestinal cell apoptosis in the diabetic control group. Treatment with PTY-2 decreases stress by upregulating SOD expression and by downregulating the expression of DPP-IV. These PTY-2 recoveries contribute to the suppression of apoptosis in the intestinal cells. CONCLUSION: The protective action of PTY-2 against STZ mediated intestinal damage is demonstrated by these short studies. Therefore, PTY-2 may be taken as a herbal remedy for diabetes-induced intestinal damages.

2019 ◽  
Author(s):  
Shivani Srivastava ◽  
Harsh Pandey ◽  
Surya K Singh ◽  
Yamini Bhusan Tripathi

ABSTRACTEnhanced DPP-IV expression is found to get enhanced in various intestinal diseases. PTY-2 has already been known to have DPP-IV inhibitory potential. This inhibition has not yet been studied at mRNA level. Increased incretin secretion due to DPP-IV inhibition could lead to suppression of stress & intestinal cells apoptosis. Through histological analysis, we have found morphological damage of intestine after STZ injection (65 mg/kg bw) to male Charles foster rats. mRNA expressions were analyzed by PCR and apoptosis of cells was checked through tunnel assay & Bcl 2 expression. The number and length of villi get reduced in STZ induced diabetic control, but these damages have been getting reversed after the PTY-2 treatment for 10 days. The expression of SOD was found to get reduced while that of DPP-IV was enhanced in diabetic control group along with significant intestinal cell apoptosis. PTY-2 treatment reduces the stress by upregulating the expression of SOD and through downregulation of DPP-IV mRNA expression. These recoveries by PTY-2 leads to suppression of intestinal cells apoptosis. These short studies explain the protective action of PTY-2 against STZ induced intestinal damage. Hence, PTY-2 could be taken as an herbal treatment against intestinal disorders in case of chronic diabetes.


Author(s):  
Н.Н. Хлебникова ◽  
С.Д. Ширенова ◽  
Н.А. Крупина

Введение. Ингибиторы пролинспецифической сериновой протеазы дипептидилпептидазы IV (ДПП-IV, CD26, EC 3.4.14.5), способные модулировать широкий спектр физиологических процессов, находят применение в клинике. В наших работах получены свидетельства влияния ингибиторов ДПП-IV при их введении в раннем постнатальном периоде на эмоционально-мотивационное поведение взрослых крыс. Более сильные изменения в поведении отмечались у крыс при действии ингибитора ДПП-IV дипротина А. Однако не ясно, как долго сохраняются такие изменения. Цель работы - изучение отсроченных эффектов ингибитора ДПП-IV дипротина А на выраженность эмоционально-мотивационных расстройств, индуцированных действием ингибитора в раннем постнатальном периоде, в динамике взросления крыс от 2 до 7 мес. Методика. Дипротин А вводили крысятам ежедневно в 5-18-й постнатальные дни внутрибрюшинно (2 мг/кг), в объеме 0.1 мл на 10 г массы тела. Крысята контрольной группы получали инъекции физиологического раствора. Поведение взрослых крыс оценивали в возрасте 2 и 7 мес в тестах автоматизированного «открытого поля», «Приподнятый крестообразный лабиринт» (ПКЛ), принудительного плавания и социального взаимодействия. Уровень кортикостерона в сыворотке крови определяли методом твердофазного иммуноферментного анализа ELISA. Для статистической обработки результатов использовали двухфакторный дисперсионный анализ Two Way ANOVA и непараметрический U-критерий Манна-Уитни с поправкой на множественность сравнений. Результаты. У крыс опытной группы по сравнению с контрольной группой в возрасте 2 и 7 мес была повышена двигательная активность и скорость перемещения в тесте ПКЛ. В возрасте 7 мес у них также была увеличена вертикальная исследовательская активность. Признаков повышения тревожности не выявлено. У крыс опытной группы выявлены признаки депрессивно-подобного поведения по нарушению биоритмологической структуры плавания, более выраженные в возрасте 7 мес. Неагрессивное социальное взаимодействие у крыс, получавших неонатально дипротин А, было снижено по сравнению с контролем в возрасте 2 мес, а в возрасте 7 мес, напротив, увеличено. У этих животных число и длительность агрессивных социальных контактов были увеличены по сравнению с контролем как в возрасте 2, так и в возрасте 7 мес. Уровень кортикостерона в сыворотке крови у крыс опытной группы в возрасте 7.5 мес был выше, чем в контроле. Заключение. Данные настоящего исследования свидетельствуют о развитии гиперактивного фенотипа и длительных психоэмоциональных нарушений в виде повышенной агрессивности наряду с активацией гипоталамо-гипофизарно-адреналовой оси у взрослых крыс, подвергнутых действию дипротина А в 5-18-й постнатальные дни, и поддерживают представления об участии дипептидилпептидазы-IV в генезе психоэмоциональных расстройств. Background. Inhibitors of the proline-specific serine protease dipeptidyl peptidase IV (DPP-IV, CD26, EC 3.4.14.5) may modulate a wide range of physiological processes and are used in the clinic. In our studies, we obtained evidence for the impact of DPP-IV inhibitors on adult rats’ emotional and motivational behavior when administered in the early postnatal period. Diprotin A exhibited the most significant impact on the animals’ behaviors. However, it is not clear how long the changes persist. Aim. To study the delayed effects of the DPP-IV inhibitor diprotin A on the severity of emotional and motivational disorders induced by the inhibitor action in the early postnatal period, in the dynamics of rats maturation from 2 to 7 months. Methods. Diprotin A was administered to rat pups daily on postnatal days 5-18, intraperitoneally, at a dose of 2 mg/kg, in a volume of 0.1 ml per 10 g of body weight. The rat pups of the control group received saline. The behavior of adult rats was assessed at the age of 2 and 7 months in the automated “open field,” “Elevated Plus Maze” (EPM), forced swimming, and social interaction tests. Serum corticosterone levels were determined by ELISA. The results were statistically processed using Two Way ANOVA and nonparametric Mann-Whitney U-test adjusted for multiple comparisons. Results. Experimental rats increased motor activity and travel speed in the EPM test compared with the control group at 2 and 7 months of age. At the age of 7 months, experimental rats also increased vertical (rearing) activity. There were no signs of increased anxiety. Experimental rats demonstrated depression-like behavior judged by the biorhythmologic structure of swimming, more pronounced at 7 months. Non-aggressive social interaction in rats treated neonatally with diprotin A was reduced compared with controls at the age of 2 months and, on the contrary, increased at the age of 7 months. In these animals, the number and duration of aggressive social contacts were increased compared with controls at the ages of 2 and 7 months. Serum corticosterone levels in experimental rats at the age of 7.5 months were higher than in control. Conclusion. The present study results testify to the development of a hyperactive phenotype and prolonged psychoemotional disorders as increased aggressiveness along with hypothalamic-pituitary-adrenal axis activation in adult rats exposed to the action of diprotin A on postnatal days 5-18. The data support the dipeptidyl peptidase IV involvement in the genesis of psychoemotional disorders.


2020 ◽  
Vol 16 ◽  
Author(s):  
Lucas Ribeiro dos Santos ◽  
Marcio Luis Duarte ◽  
Maria Stella Peccin ◽  
Antônio Ricardo de Toledo Gagliardi ◽  
Tamara Melnik

Introduction:: Hepatic steatosis is a frequent condition, that afflicts, especially, obese and insulin resistant patients; diagnosis is made, usually, through imaging tests. Despite the high prevalence and risk of complications, there is no specific treatment approved, though a vast number of medications have been tested. Objective:: To determine the efficacy of dipeptidyl peptidase IV inhibitors (i DPP-IV) in the treatment of NAFLD. Methods:: We searched the electronic databases of the Cochrane Library, MEDLINE, EMBASE and LILACS, as well as reference lists of the included studies and grey literature; 9 studies were selected for inclusion. Results:: 7 studies were used for metanalysis, for 3 outcomes. i DPP-IV showed an ALT-reducing power of MD -10.83 [95% CI 35.23 to 13.57] at 3 months and MD -9.27 [95% CI 10.92 to -7.62] at 6 months of intervention, as well as reduction of hepatic steatosis via MRI of SMD 0.10 [95% CI 0.31 to 0.50]; the overall incidence of adverse events was very low. The studies were considered of low and very low quality by the GRADE evaluation. Conclusion:: Because of the poor overall quality of the studies and heterogeneity of the population analyzed, i DPP-IV did not show efficacy on inflammatory markers or fibrosis in patients with NAFLD.


2017 ◽  
Vol 8 (6) ◽  
pp. 2249-2257 ◽  
Author(s):  
A. B. Nongonierma ◽  
M. Hennemann ◽  
S. Paolella ◽  
R. J. FitzGerald

Wheat gluten hydrolysates contain known/potential DPP-IV inhibitory peptides.


2019 ◽  
Vol 279 ◽  
pp. 70-79 ◽  
Author(s):  
Alice B. Nongonierma ◽  
Cloé Cadamuro ◽  
Aurélien Le Gouic ◽  
Priti Mudgil ◽  
Sajid Maqsood ◽  
...  

2021 ◽  
Author(s):  
Yoshinori Takahashi ◽  
Akira kamata ◽  
Mie Nishimura ◽  
Jun Nishihira

Salmon milt peptide (SMP), an unused fish processing byproduct, exhibits strong inhibitory activity against dipeptidyl peptidase-IV (DPP-IV) and a suppressive effect on postprandial hyperglycaemia in Sprague–Dawley rats.Herein, we conducted a...


Sign in / Sign up

Export Citation Format

Share Document